Jiangsu Hengrui Medicine
600276.SS
#401
Rank
ยฃ43.41 B
Marketcap
ยฃ6.54
Share price
0.60%
Change (1 day)
22.64%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Cash on Hand

Cash on Hand as of June 2025 : ยฃ3.79 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has ยฃ3.79 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Jiangsu Hengrui Medicine - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ2.73 B18.35%
2023-12-31ยฃ2.31 B8.07%
2022-12-31ยฃ2.14 B-1.6%
2021-12-31ยฃ2.17 B17.75%
2020-12-31ยฃ1.84 B24.84%
2019-12-31ยฃ1.48 B15.83%
2018-12-31ยฃ1.27 B163.4%
2017-12-31ยฃ0.48 B-15.35%
2016-12-31ยฃ0.57 B7.27%
2015-12-31ยฃ0.53 B49.38%
2014-12-31ยฃ0.35 B64.65%
2013-12-31ยฃ0.21 B64.71%
2012-12-31ยฃ0.13 B35.75%
2011-12-31ยฃ97.18 M-0.3%
2010-12-31ยฃ97.48 M52.35%
2009-12-31ยฃ63.98 M37.34%
2008-12-31ยฃ46.58 M-19.98%
2007-12-31ยฃ58.22 M54.41%
2006-12-31ยฃ37.7 M21.6%
2005-12-31ยฃ31 M35.39%
2004-12-31ยฃ22.9 M68.44%
2003-12-31ยฃ13.59 M-5.71%
2002-12-31ยฃ14.42 M-36.14%
2001-12-31ยฃ22.58 M-42.32%
2000-12-31ยฃ39.14 M427.93%
1999-12-31ยฃ7.41 M256.75%
1998-12-31ยฃ2.07 M7.35%
1997-12-31ยฃ1.93 M